Home » Gender affirmation, stop to puberty suppressing drugs. What is the risk?

Gender affirmation, stop to puberty suppressing drugs. What is the risk?

by admin
Gender affirmation, stop to puberty suppressing drugs.  What is the risk?

England Limits Prescription of Puberty-Suppressing Drugs for Minors

In a move that has sparked controversy, England has become the fifth country to restrict the prescription of puberty-suppressing drugs to minors. The decision, made by the English Health Service, aims to discourage children, young people, and their families from obtaining puberty blockers from online suppliers in order to affirm their desired gender.

The decision comes amidst concerns about the effectiveness and potential risks of these drugs. Recent studies have shown little data to prove that puberty blockers improve the mental health of individuals with gender dysphoria, while also reporting possible negative effects on bone health during the developmental phase.

Puberty is a crucial period in a person’s life, with physical, neuronal, and psychological transformations occurring. It is a time of significant change and development, and any interventions, such as the use of puberty-suppressing drugs, should be approached with caution.

Gender dysphoria, previously labeled as a mental disorder, is when a person experiences distress because their gender identity does not align with their biological sex. It is important to address these issues in a thoughtful and informed manner, considering the long-term implications for the individual’s well-being.

The decision to limit the prescription of puberty-suppressing drugs in England has raised concerns among groups and associations working on gender issues. They fear that this move may hinder the progress made in supporting and assisting minors with gender variance. There are also worries that the findings of these studies could be exploited for ideological purposes rather than public health reasons.

See also  Travel health care, what is covered with the health card? Be careful or you risk a huge bill upon return

It is crucial to strike a balance between providing support and care for individuals experiencing gender dysphoria while also ensuring that any interventions are based on sound scientific evidence and prioritize the well-being of the individual. The decision in England highlights the ongoing debate and challenges surrounding gender identity and the use of medical interventions in supporting individuals with gender dysphoria.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy